Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JPMHC 2021
JPMHC 2021
J.P. Morgan: Will Biotech’s Virtual 2021 Launch Become the New Reality?
BioSpace
Wed, 01/27/21 - 12:15 pm
virtual meetings
biotech
JPMHC 2021
JPM: 'Stick a fork in it'—J.P. Morgan in San Francisco is done, reader poll results say
Fierce Pharma
Mon, 01/18/21 - 01:23 pm
JPMHC
JPMHC 2021
virtual meetings
pandemic
Final Highlights from the 2021 J.P. Morgan Healthcare Conference
BioSpace
Sat, 01/16/21 - 11:57 pm
JPMHC 2021
intravenous immunoglobulin
IDEAYA Biosciences
Jounce Therapeutics
Puma Biotechnology
JPM: Established relationships were key to pandemic drug launches, Incyte CEO says
Fierce Pharma
Sat, 01/16/21 - 11:48 pm
COVID-19
pandemic
drug launches
Incyte
JPMHC 2021
Intuitive, J&J, Medtronic and Zimmer talk robotic surgery ambitions: JPM21
Medtech Dive
Thu, 01/14/21 - 10:44 pm
JPMHC 2021
robotic surgery
devices
Intuitive Surgical
JNJ
Medtronic
Zimmer Biomet
JPM: Jazz eyes a 'dramatic' shift to new-drug revenue by 2022, CEO says
Fierce Pharma
Thu, 01/14/21 - 10:37 pm
Jazz Pharmaceuticals
JPMHC 2021
#JPM21: Avidity CSO Art Levin runs full speed to the clinic with 'dream' antibody oligonucleotide conjugate therapy
Endpoints
Thu, 01/14/21 - 10:34 am
Avidity
JPMHC 2021
oligonucleotide-based therapies
muscle diseases
JPM: How did Pfizer up its COVID-19 vaccine capacity? 'Out of the box manufacturing,' CEO says
Fierce Pharma
Wed, 01/13/21 - 11:41 pm
Pfizer
BioNTech
vaccines
COVID-19
JPMHC 2021
drug manufacturing
Albert Bourla
JPM: Sanofi's new chief digital officer steps up ambitions in marketing, research and even e-commerce
Fierce Pharma
Wed, 01/13/21 - 11:29 pm
JPMHC 2021
Sanofi
digital pharma
JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran
Fierce Biotech
Wed, 01/13/21 - 10:53 am
CureVac
Bayer
vaccines
COVID-19
JPMHC 2021
A longtime Pfizer chief's ultra-quiet biotech re-emerges with new cash and plans for the clinic
Endpoints
Wed, 01/13/21 - 10:49 am
Elucida Oncology
Pfizer
JPMHC 2021
JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping
Fierce Pharma
Wed, 01/13/21 - 12:13 am
JPMHC 2021
COVID-19
pandemic
R&D
drug marketing
David Ricks
Stephane Bancel
Pharma CEOs
JPM21: Vaccines soar, antibodies struggle as COVID-19 drugs become a business
BioPharma Dive
Wed, 01/13/21 - 12:06 am
JPMHC 2021
pandemic
COVID-19
JPM Week: Will the first COVID-19 vaccines deter future launches? Not at all, experts say
Fierce Pharma
Tue, 01/12/21 - 11:13 am
vaccines
pandemic
COVID-19
JPMHC 2021
JPM: Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
Fierce Biotech
Tue, 01/12/21 - 11:11 am
JPMHC 2021
Verve Therapeutics
VERVE-101
familial hypercholesterolemia
Key takeaways from BioNTech CEO’s JPM presentation
MedCity News
Tue, 01/12/21 - 11:05 am
JPMHC 2021
BioNTech
vaccines
COVID-19
MRNA
JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how pharma works
Fierce Biotech
Tue, 01/12/21 - 11:04 am
JPMHC 2021
pandemic
Novartis
COVID-19
R&D
JPM: Boehringer inks Enara deal to source 'dark antigens' for cancer immunotherapies
Fierce Biotech
Tue, 01/12/21 - 11:00 am
JPMHC 2021
Boehringer Ingelheim
Enara Bio
dark antigens
cancer
cancer vaccines
JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data
Fierce Pharma
Tue, 01/12/21 - 10:57 am
JNJ
JPMHC 2021
vaccines
COVID-19
clinical trials
JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining
BioPharma Dive
Mon, 01/11/21 - 07:06 pm
JPMHC 2021
Biogen
Vertex Pharmaceuticals
Sarepta Therapeutics
Pages
1
2
next ›
last »